What is Compass Pathways Plc's share price today?
Compass Pathways Plc (CMPS) share price today is $11.11 as of October 27, 2026 at 12:18 AM IST. The stock touched a day high of $11.28 and a day low of $10.96.What exchange does Compass Pathways Plc stock trade on, and under what ticker symbol?
Compass Pathways Plc stock trades on NASDAQ under the ticker symbol CMPS.What is Compass Pathways Plc's market capitalization?
Compass Pathways Plc's market capitalization is $1.54B as of October 27, 2026 at 12:18 AM IST.What is Compass Pathways Plc's price-to-earnings (P/E) ratio?
Compass Pathways Plc's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.What is Compass Pathways Plc's price-to-book (P/B) ratio?
Compass Pathways Plc's price-to-book (P/B) ratio is 3.54 as of October 26, 2026.Can Indian investors buy Compass Pathways Plc shares?
Yes, You can buy Compass Pathways Plc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Compass Pathways Plc shares from India?
Indian investors can buy Compass Pathways Plc shares in three steps: 1. Search Compass Pathways Plc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Compass Pathways Plc shares for Indian investors?
Since Compass Pathways Plc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Compass Pathways Plc shares via Tickertape?
Indian investors can start investing in Compass Pathways Plc (CMPS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.8996 shares at the current price of $11.11.
$
₹
$11.110.58% (-0.06)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
3.54
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-3.76
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 16 analysts reports
Buy15 analysts
Hold1 analyst
Sell0 analyst
Price Upside
+112.43%
Earnings Growth
+17.15%
Rev. Growth
—
Company Profile
Company Profile
P/E Ratio
24.59
24.59
1Y Return
15.29%
15.29%
Buy Reco %
92.59
92.59
P/E Ratio
12.68
12.68
1Y Return
0.61%
0.61%
Buy Reco %
75.00
75.00
P/E Ratio
24.09
24.09
1Y Return
32.01%
32.01%
Buy Reco %
52.94
52.94
P/E Ratio
27.20
27.20
1Y Return
16.13%
16.13%
Buy Reco %
72.22
72.22
P/E Ratio
—
—
1Y Return
143.8%
143.8%
Buy Reco %
96.15
96.15
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$11.18Baseline
Analyst Target - 1 year
Target$23.75+112.43%
All values in $
2026
Current$11.18Baseline
Analyst Target - 1 year
Target$23.75+112.43%
All values in $
Earnings Per Share Forecast
Earnings Per Share Forecast
2025
Current$-1.82Baseline
Forecast for Dec 2026
High$-1.07+41.1%
Average$-1.5+17.15%
Low$-2.28-25.52%
All values in $
2025
Current$-1.82Baseline
Forecast for Dec 2026
High$-1.07+41.1%
Average$-1.5+17.15%
Low$-2.28-25.52%
All values in $
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0.06 | -0.06 | - | - | - | -0.15 | -0.01 | -0 | - | - |
| Net Income | -35.18 | -38.10 | -38.50 | -43.33 | -17.86 | -38.40 | -137.71 | -93.87 | 91.20 | -253.79 |
| Net Profit Margin | - | - | - | - | - | - | - | - | - | - |
Peers
Peers & Comparison
Peers & Comparison
Comparing 2 stocks from
HealthcareMedical Care Facilities
HealthcareMedical Care Facilities
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Compass Pathways Plc | - | 3.54 | - |
| CVS Health Corp | 24.59 | 1.44 | 0.21 |
| Cigna Corp | 12.68 | 1.71 | 0.75 |
Price Comparison
Price Comparison
Compare CMPS with any stock or ETFCompare CMPS with any stock or ETF
Comparing from
CMPS
CVS
CI
The 12-month consensus target implies 112.43% growth, versus a trailing 3-year CAGR of 26.37%.